.Pharmacolibrary.Drugs.N_NervousSystem.N03A_Antiepileptics.N03AA04_Barbexaclone.Barbexaclone .Pharmacolibrary.Drugs.N_NervousSystem.N03A_Antiepileptics.N03AA04_Barbexaclone.Barbexaclone| name: | Barbexaclone | |
| ATC code: | N03AA04 | route: | oral |
| compartments: | 1 | |
| dosage: | 100 | mg |
| volume of distribution: | 0.7 | L |
| clearance: | 3 | ml/min/kg |
| other parameters in model implementation | ||
Barbexaclone is a salt combination of phenobarbital and levopropylhexedrine, formerly used as an anticonvulsant for the treatment of epilepsy and sometimes as a sedative. It is no longer widely marketed or approved for use in most countries. The compound was purported to have efficacy similar to phenobarbital with improved tolerability.
No published pharmacokinetic data for barbexaclone as a combination product identified in literature or regulatory databases as of 2024. The pharmacokinetic parameters are therefore estimated based on known properties of phenobarbital, the active component.